The company will pursue a multi-dimensional strategic focus based on the development of multiple oxygen-based therapies; strategic patenting and patent acquisitions; as well as excellence in research and clinical development.

Our primary goals include:

• Making Oxycyte the first oxygen carrier for traumatic brain injury and sickle-cell crisis
• Developing a multiple-product portfolio
• Achieving profitability through licensing
• Seeking access to major capital markets

Vision/Mission

Business Concept